# Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong

> **NCT04096963** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 50 (actual)

## Conditions studied

- Non-valvular Atrial Fibrillation

## Interventions

- **DEVICE:** The WATCHMAN FLX Delivery System

## Key facts

- **NCT ID:** NCT04096963
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-19
- **Primary completion:** 2022-01-24
- **Final completion:** 2023-03-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096963, "Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04096963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*